DBNascent | Samples

SRR3619367,SRR3619368,SRR3619369,...

**Downloads**
Gene read counts	Bidirectional read counts	Tfit regions	dREG regions
ZIP archive	ZIP archive	ZIP archive	ZIP archive
For TDF visualization files please see individual sample downloads or dataset pages for prebuilt ZIP archives.

**Technical details**
Sample name	Sample ID	Paper identifier	Protocol	Library prep	Control/Experimental	Wildtype & Untreated	QC score	Replicate
SRR3619367	2529	Vian2018energetics	GRO-seq	circularization	experimental	False	3	1
SRR3619368	2530	Vian2018energetics	GRO-seq	circularization	experimental	False	3	1
SRR3619369	2531	Vian2018energetics	GRO-seq	circularization	control	False	3	1
SRR6794626	2532	Vian2018energetics	RNA-seq variant	ligation	control	True	2	1
SRR6794627	2533	Vian2018energetics	RNA-seq variant	ligation	control	True	3	2
SRR6794628	2534	Vian2018energetics	RNA-seq variant	ligation	experimental	False	2	1
SRR6794629	2535	Vian2018energetics	RNA-seq variant	ligation	experimental	False	2	2

**Cellular details**
Sample name	Organism	Sample type	Cell type	Clone/Individual	Strain	Genotype	Construct
SRR3619367	M. musculus	primary cell	splenic B cell			Myc fl/fl; tamoxifen-inducible Cre/+
SRR3619368	M. musculus	primary cell	splenic B cell			Myc fl/fl
SRR3619369	M. musculus	primary cell	splenic B cell			Myc fl/fl
SRR6794626	M. musculus	cell line	PCT 7134
SRR6794627	M. musculus	cell line	PCT 7134
SRR6794628	M. musculus	cell line	PCT 7134			SA -/-
SRR6794629	M. musculus	cell line	PCT 7134			SA -/-

**Conditions**
Sample name	Condition type	Treatment	Start time	End time	Duration
SRR3619367	treatment	anti-CD180 (500 ng/mL)	-3 hr	0 hr	3 hr
	treatment	hydroxytamoxifen	None	None	None
	treatment	interleukin-4 (2.5 ng/mL)	-3 hr	0 hr	3 hr
	treatment	lipopolysaccharide (50 microg/mL)	-3 hr	0 hr	3 hr
SRR3619368	treatment	anti-CD180 (500 ng/mL)	-3 hr	0 hr	3 hr
	treatment	interleukin-4 (2.5 ng/mL)	-3 hr	0 hr	3 hr
	treatment	lipopolysaccharide (50 microg/mL)	-3 hr	0 hr	3 hr
SRR3619369	no treatment		None	None	None
SRR6794626	no treatment		None	None	None
SRR6794627	no treatment		None	None	None
SRR6794628	no treatment		None	None	None
SRR6794629	no treatment		None	None	None

**Sample metrics**
Sample name	Raw read length	Trim read depth	Duplication proportion	Proportion reads mapped	Exon/intron ratio	Unique read proportion	Sample QC score	Sample NRO score
SRR3619367	50	196,649,519	0.65764	0.795	4.07568	0.56229	3	2
SRR3619368	50	211,566,039	0.69495	0.7961	4.06885	0.51838	3	2
SRR3619369	50	213,400,571	0.72688	0.793	2.97581	0.48174	3	1
SRR6794626	35	88,944,127	0.56047	0.8712	4.92631	0.73928	2	2
SRR6794627	35	103,825,671	0.70994	0.8544	6.62782	0.64939	3	3
SRR6794628	35	114,677,567	0.62237	0.8721	4.93232	0.74201	2	2
SRR6794629	35	100,811,936	0.61671	0.8594	5.56522	0.70931	2	3

**Bidirectionals**
Sample name	Tfit total bidirs	Tfit promoter bidirs	Tfit intronic bidirs	Tfit intergenic bidirs	dREG total bidirs	dREG promoter bidirs	dREG intronic bidirs	dREG intergenic bidirs
SRR3619367	24284	11178	6573	4630	29771	5438	12260	9396
SRR3619368	22383	10571	6288	3828	28015	5187	11752	8578
SRR3619369	24534	10582	7042	4925	29556	5749	12350	8776
SRR6794626	None	None	None	None	None	None	None	None
SRR6794627	None	None	None	None	None	None	None	None
SRR6794628	None	None	None	None	None	None	None	None
SRR6794629	None	None	None	None	None	None	None	None